SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Carson O. Ray, Jr. who wrote (62)6/12/1997 1:35:00 AM
From: nelli   of 258
 
SANG is exactly the picture I had in mind. 21 to 16 to 13 to 20 to 25, I like that very much. Granted, though, SANG has a LOT more than MATK. I was too much of a chicken to buy into SANG but you can bet I watched it with an eagle eye, wishing I had the guts, and the cash to buy it low, boy oh, boy, what could have been.

11.385(current price) x 13.5 million shares outstanding
= 153.7 million market cap.

That doesn't sound bad to me at all.

I read somewhere that MATK will be at an investor conference soon, in the next week I think, that should help...

Bill Small where are you?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News